Dear valued Future Generics user,

Future Generics contains a wealth of information about pharmaceutical active ingredients, as well as veterinary, agrochemicals and nutraceuticals compounds.

One of the set of data is the Supplementary Protection Certificate. So far, B&A FGD database is covering 20 countries (Austria, Belgium, Denmark, Estonia, Finland, France, Germany, Iceland, Ireland, Italy, Japan, Luxemburg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK and USA).

Becker and Associates is dedicated to provide you with the best data available in the most powerful database.

We worked, and will continue to work hard, to reorganise these SPC data.
First, we collected and prepared the data for 11 more countries: Albania, Bulgaria, Czech Republic, Hungary, Israel, Latvia, Lithuania, Poland, Romania, Slovak Republic and Slovenia.
Secondly, we improved the data quality and quantity for the countries we were following already:

  • – we are adding now the list of the Market Authorisation Data linked to the SPC
  • – we are making a better distinction between a SPC and an Extension of SPC, so you can better follow which MA are extended and which are not.

However, keep in mind that each country publishes a certain amount of data, and a certain number of status only.

To be able to get these upgraded data, we need to rebuild the structure of the database.

We hope that these new data will help you to do better business by helping you identifying new targets for you company.

Best regards,